Chris Hurt
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Somnath Mukherjee (33 shared papers)Gareth Griffiths (34 shared papers)John Staffurth (21 shared papers)Tim Maughan (28 shared papers)T. Crosby (16 shared papers)Stephen Falk (17 shared papers)Ruby Ray (15 shared papers)John Bridgewater (14 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)British Journal of Cancer (11 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Clinical Oncology (6 papers)Radiotherapy and Oncology (6 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Chris Hurt
116 papers receiving 2.7k citations
Chris Hurt's Hit Papers
Peers
Comparison fields: 5 of 137
- Otorhinolaryngology 234
- Oncology 722
- Surgery 836
- Pulmonary and Respiratory Medicine 521
- Cancer Research 150
Countries citing papers authored by Chris Hurt
This map shows the geographic impact of Chris Hurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Hurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Hurt more than expected).
Fields of papers citing papers by Chris Hurt
This network shows the impact of papers produced by Chris Hurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Hurt. The network helps show where Chris Hurt may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Hurt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial Hit paper breakdown → | 2013 | 281 |
| 2 | 2013 | 259 | |
| 3 | 2015 | 196 | |
| 4 | 2013 | 113 | |
| 5 | 2010 | 91 | |
| 6 | 2011 | 90 | |
| 7 | 2006 | 87 | |
| 8 | 2008 | 82 | |
| 9 | 2016 | 81 | |
| 10 | 2014 | 72 | |
| 11 | 2008 | 66 | |
| 12 | 2002 | 66 | |
| 13 | 2012 | 58 | |
| 14 | 2017 | 54 | |
| 15 | 2017 | 50 | |
| 16 | 2014 | 49 | |
| 17 | 2006 | 48 | |
| 18 | 2018 | 42 | |
| 19 | 2019 | 41 | |
| 20 | 2012 | 39 |
About Chris Hurt
Chris Hurt is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 125 papers that have together received 2.8k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (26 papers), Pancreatic and Hepatic Oncology Research (19 papers), Radiomics and Machine Learning in Medical Imaging (11 papers), Gastric Cancer Management and Outcomes (10 papers), Head and Neck Cancer Studies (8 papers), Cancer Genomics and Diagnostics (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Otorhinolaryngology (234 citations), Oncology (722 citations), Surgery (836 citations), Pulmonary and Respiratory Medicine (521 citations) and Cancer Research (150 citations). Chris Hurt has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Somnath Mukherjee, Gareth Griffiths, John Staffurth, Tim Maughan, T. Crosby, Stephen Falk, Ruby Ray, John Bridgewater, Tom Crosby and Rajarshi Roy. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, Clinical Oncology and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.